Sophia's Story
Dan Lewis Foundation | Summer 2024

Every Traumatic Brain Injury story is different, and the outcome for individuals is often unpredictable



This is Sophia Augier's story

On February 26th, 2023, I glided over the freshly powdered slopes of Vermont as the flurries melted against my wind-burned cheeks. The twists and turns of the Rollercoaster Trail left me with an adrenaline high. Each jump I landed fed the thrill of the ride until I was suddenly consumed by darkness, and after the accident, my senior year turned into a nightmare. High school had gone exactly as planned. After years of hard work, late-night study sessions, and an activity-packed resume, I was set to attend the Massachusetts Institute of Technology (MIT) in the fall. My future was brighter than ever, but that single moment on the slopes left my future in jeopardy. Instead of celebrating my achievements, I was confined to a dark basement, stripped of social interaction, grappling with excruciating physical pain and overwhelming fear. Day after day, I sat there alone, trying to weed through the unknowns and search for a glimpse of hope. My dreams of MIT felt impossible as I struggled with memory loss, severe headaches, and an inability to read or even step outside.

As the days passed, the events of that fateful day slowly returned to me. The edge of my board clipped the snow so fast, sending me tumbling before I could react. When I regained consciousness, I was met with blood-stained snow through waves of darkness. Having lost control of my bladder, I found myself soaked to the bone and gasping for air as my face pressed against the snow. Despite this, I forced myself to get up and make it down the mountain. Embarrassed, I brushed off the incident and continued with my day. With the fresh snow the following morning, I ignored a nagging headache and returned to the slopes. It wasn't until the ride home that overwhelming nausea forced me to acknowledge something was wrong. Days later, my symptoms worsened, but they aligned with a typical flu rather than a traumatic brain injury. Initially misdiagnosed with mononucleosis by my physician, it took an emergency room visit to finally confirm my concussion. The unfortunate waiting period had consequently worsened my symptoms and prolonged my recovery. Finally, a specialist confirmed my worst fears. While the flu-like symptoms faded, my blurry vision, memory loss, and headaches persisted. The prospect of MIT seemed more distant than ever. Returning to school felt surreal; I could barely participate in classes. Watching my friends celebrate their college commitments, I felt like a kindergartner in a 12th-grader's body while I sat in a dimly lit corner, unsure if I'd ever think like myself again.


Months of vision therapy and rehabilitation followed. The drive and grit that fueled my academic success now drove my recovery. Slowly but surely, the darkness lifted, and I began to see a future again. My hard work paid off, and I regained the ability to pursue my dreams.


Today, I have just completed my first year at MIT. I joined the Division 1 crew team, worked for the MIT ambulance service and made lifelong friends. As I write this from my apartment in Cape Town, South Africa, where I'm conducting engineering research, I reflect on my journey.


My experience taught me that life's path is unpredictable. Adversity can strike at any moment, but it's how we respond that defines us. The pain and fear I endured were real, but they also revealed a resilience I didn't know I had. Embracing this resilience, I learned to navigate the unexpected and emerge into the strong woman I am today. In the grand scheme of life, our challenges are as much a part of our story as our achievements. My traumatic brain injury was a test of my strength and determination, and it reshaped my understanding of success. True success isn't just about reaching our goals; it's about finding the courage to keep going when those goals seem out of reach. My journey through concussion and recovery has been my greatest teacher, showing me that resilience, determination, and hope are the keys to navigating life's rollercoaster ride.


Sophia Augier

The word arpah is written in blue letters on a white background.
By Dan Lewis Foundation July 31, 2025
On July 10, 2025, the Advanced Research Projects Agency for Health (ARPA-H) announced a major initiative titled Functional Repair of Neocortical Tissue or FRONT. The announcement states “FRONT will pioneer a curative therapy for the more than 20 million adults in the US living with chronic neocortical brain damage from neurodegeneration, stroke, trauma, and other causes, which costs the country an estimated $800 billion per year. Worldwide, more than 200 million people live with debilitating after-effects of brain damage.”  A set of informational meetings about this program and a due date for outlines of potential proposals have been set for August. Full proposals are due by September 25, 2025. Complete instructions, specifications, and expectations are delineated in the ARPA-H FRONT announcement. The FRONT announcement includes a clear expectation that the successful brain regeneration methods that are discovered will be used in clinical trials with persons with brain injury by the fifth year of the program. The DLF lauds ARPA-H for initiating this program. We are discussing possibilities for playing a supportive role as proposals develop. This exciting program is congruent with the original overarching goals of the DLF and confirms the validity of its mission.
Photo of Dr. Justin Burrell
By Dan Lewis Foundation July 31, 2025
Dr. Burrell is a translational neuroengineer in the Departments of Neurosurgery and Oral & Maxillofacial Surgery at the University of Pennsylvania. His research integrates advanced neural repair strategies with clinical translation, focusing on axon protection, nerve fusion, and engineered neural tissue for neurotrauma recovery. Dr. Burrell has led the development of multiple first-in-field innovations—including the first large-animal model of nerve fusion, delayed axonal fusion protocols, and the first orally active axonal protectants—positioning him as a recognized leader in regenerative neurotechnologies. He is co-founder of Neurostorative LLC and plays a central role in several other platforms aimed at neural reconnection, long-term preservation, and bio-integrated prosthetic systems.